Leadership appointment

#Leadership appointment #Life sciences #Microfluidics #Nuclera

Nuclera appoints Carl Raimond as Chief Executive Officer 

Nuclera has appointed Carl Raimond as Chief Executive Officer, effective immediately. Dr Michael Chen, Nuclera’s Co-founder and former CEO, transitions to the role of Chief Scientific and Business Officer, continuing to provide scientific leadership while supporting market development and strategic partnerships.  The leadership transition reportedly marks the… Read More

#News

#Leadership appointment #New appointment #Numab Therapeutics

Dr Rajesh Chopra joins Numab Therapeutics as Chief Scientific Officer

Numab Therapeutics has appointed Dr Rajesh Chopra as Chief Scientific Officer, who brings nearly four decades of experience across oncology, immunology, translational medicine, and drug development.  Dr Chopra joined Numab from Prologue Medicines, where he served as Chief Scientific Officer, and previously was a Venture Partner at… Read More

#News

Human cells
#Cell analysis #Cytomos #Leadership appointment #Life sciences

Cytomos appoints board member to support commercialisation drive

Edinburgh-based biotechnology company Cytomos has appointed senior life sciences executive Dr Alex Jones as non-executive director, as it looks to accelerate the commercialisation of its cell analysis technology. Dr Jones brings extensive expertise in life science tools and cell and gene therapy. As the incumbent CEO of Cellply, and previously… Read More

#News

Neurones in the brain
#Leadership appointment #MindMaze Therapeutics #Neuroplasticity #Neuroscience #New appointment

MindMaze Therapeutics appoints strategic advisor for US growth

MindMaze Therapeutics has appointed Dr John Krakauer as a strategic advisor to support its next phase of growth in the United States.  “John has shaped the science behind our platform for years, and his foundational work is central to how we think about recovery,” said Zach Henderson, CEO of MindMaze Therapeutics. “As… Read More

#News